

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 5.98816001 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.98816001 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 5.70149079 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.70149079 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.05692906 |
| 6 | protein neddylation (GO:0045116) | 4.95447764 |
| 7 | short-chain fatty acid metabolic process (GO:0046459) | 4.66554059 |
| 8 | fatty acid beta-oxidation (GO:0006635) | 4.65932917 |
| 9 | branched-chain amino acid catabolic process (GO:0009083) | 4.63584009 |
| 10 | glyoxylate metabolic process (GO:0046487) | 4.60152260 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.51987192 |
| 12 | regulation of sequestering of triglyceride (GO:0010889) | 4.50551414 |
| 13 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.47834471 |
| 14 | fatty acid oxidation (GO:0019395) | 4.35269325 |
| 15 | lipid oxidation (GO:0034440) | 4.28536230 |
| 16 | fatty acid catabolic process (GO:0009062) | 4.28276552 |
| 17 | indole-containing compound catabolic process (GO:0042436) | 4.27204851 |
| 18 | indolalkylamine catabolic process (GO:0046218) | 4.27204851 |
| 19 | tryptophan catabolic process (GO:0006569) | 4.27204851 |
| 20 | lysine catabolic process (GO:0006554) | 4.22842332 |
| 21 | lysine metabolic process (GO:0006553) | 4.22842332 |
| 22 | bile acid biosynthetic process (GO:0006699) | 4.22458919 |
| 23 | regulation of triglyceride catabolic process (GO:0010896) | 4.17009409 |
| 24 | platelet dense granule organization (GO:0060155) | 4.13156172 |
| 25 | branched-chain amino acid metabolic process (GO:0009081) | 4.12342353 |
| 26 | tryptophan metabolic process (GO:0006568) | 4.10370677 |
| 27 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.09301518 |
| 28 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.07036858 |
| 29 | cellular ketone body metabolic process (GO:0046950) | 4.05731749 |
| 30 | alpha-linolenic acid metabolic process (GO:0036109) | 3.99506470 |
| 31 | monocarboxylic acid catabolic process (GO:0072329) | 3.97351029 |
| 32 | valine metabolic process (GO:0006573) | 3.96825655 |
| 33 | coenzyme catabolic process (GO:0009109) | 3.96208646 |
| 34 | kynurenine metabolic process (GO:0070189) | 3.94226821 |
| 35 | sulfur amino acid catabolic process (GO:0000098) | 3.89197548 |
| 36 | amino-acid betaine metabolic process (GO:0006577) | 3.88489656 |
| 37 | cysteine metabolic process (GO:0006534) | 3.86699130 |
| 38 | ATP synthesis coupled proton transport (GO:0015986) | 3.85190218 |
| 39 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.85190218 |
| 40 | protein complex biogenesis (GO:0070271) | 3.84848208 |
| 41 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.83984874 |
| 42 | regulation of hexokinase activity (GO:1903299) | 3.83798667 |
| 43 | regulation of glucokinase activity (GO:0033131) | 3.83798667 |
| 44 | acetyl-CoA metabolic process (GO:0006084) | 3.81477654 |
| 45 | respiratory chain complex IV assembly (GO:0008535) | 3.81049459 |
| 46 | aromatic amino acid family metabolic process (GO:0009072) | 3.77034787 |
| 47 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.75556740 |
| 48 | protein carboxylation (GO:0018214) | 3.75556740 |
| 49 | homocysteine metabolic process (GO:0050667) | 3.75081420 |
| 50 | alpha-amino acid catabolic process (GO:1901606) | 3.72255337 |
| 51 | response to pheromone (GO:0019236) | 3.69835534 |
| 52 | serine family amino acid catabolic process (GO:0009071) | 3.65694879 |
| 53 | organic acid catabolic process (GO:0016054) | 3.64607740 |
| 54 | carboxylic acid catabolic process (GO:0046395) | 3.64607740 |
| 55 | respiratory electron transport chain (GO:0022904) | 3.63477027 |
| 56 | cellular amino acid catabolic process (GO:0009063) | 3.60559261 |
| 57 | ethanol oxidation (GO:0006069) | 3.58515903 |
| 58 | triglyceride homeostasis (GO:0070328) | 3.57846740 |
| 59 | acylglycerol homeostasis (GO:0055090) | 3.57846740 |
| 60 | tyrosine metabolic process (GO:0006570) | 3.57671217 |
| 61 | high-density lipoprotein particle remodeling (GO:0034375) | 3.56388481 |
| 62 | aspartate family amino acid catabolic process (GO:0009068) | 3.53950484 |
| 63 | electron transport chain (GO:0022900) | 3.53593167 |
| 64 | ketone body metabolic process (GO:1902224) | 3.53165092 |
| 65 | bile acid metabolic process (GO:0008206) | 3.52224112 |
| 66 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.50975924 |
| 67 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.50975924 |
| 68 | NADH dehydrogenase complex assembly (GO:0010257) | 3.50975924 |
| 69 | DNA double-strand break processing (GO:0000729) | 3.50872325 |
| 70 | fatty acid transmembrane transport (GO:1902001) | 3.48823291 |
| 71 | aldehyde catabolic process (GO:0046185) | 3.47807713 |
| 72 | succinate metabolic process (GO:0006105) | 3.47609192 |
| 73 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.45416607 |
| 74 | dopamine transport (GO:0015872) | 3.44782950 |
| 75 | carnitine metabolic process (GO:0009437) | 3.42478804 |
| 76 | tricarboxylic acid cycle (GO:0006099) | 3.42446548 |
| 77 | complement activation, alternative pathway (GO:0006957) | 3.40094034 |
| 78 | thioester metabolic process (GO:0035383) | 3.38976768 |
| 79 | acyl-CoA metabolic process (GO:0006637) | 3.38976768 |
| 80 | cellular biogenic amine catabolic process (GO:0042402) | 3.37235495 |
| 81 | amine catabolic process (GO:0009310) | 3.37235495 |
| 82 | positive regulation of fatty acid oxidation (GO:0046321) | 3.34371544 |
| 83 | 2-oxoglutarate metabolic process (GO:0006103) | 3.33598982 |
| 84 | very long-chain fatty acid metabolic process (GO:0000038) | 3.33260881 |
| 85 | cofactor catabolic process (GO:0051187) | 3.30921985 |
| 86 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.30459161 |
| 87 | cytochrome complex assembly (GO:0017004) | 3.24324903 |
| 88 | negative regulation of fibrinolysis (GO:0051918) | 3.22779190 |
| 89 | cellular glucuronidation (GO:0052695) | 3.22177009 |
| 90 | response to phenylpropanoid (GO:0080184) | 3.22020215 |
| 91 | plasma lipoprotein particle clearance (GO:0034381) | 3.21771933 |
| 92 | regulation of protein activation cascade (GO:2000257) | 3.20874854 |
| 93 | negative regulation of lipase activity (GO:0060192) | 3.20845408 |
| 94 | acyl-CoA biosynthetic process (GO:0071616) | 3.20392324 |
| 95 | thioester biosynthetic process (GO:0035384) | 3.20392324 |
| 96 | biotin metabolic process (GO:0006768) | 3.19924438 |
| 97 | plasma lipoprotein particle remodeling (GO:0034369) | 3.19551485 |
| 98 | protein-lipid complex remodeling (GO:0034368) | 3.19551485 |
| 99 | macromolecular complex remodeling (GO:0034367) | 3.19551485 |
| 100 | carnitine shuttle (GO:0006853) | 3.19364324 |
| 101 | regulation of cholesterol esterification (GO:0010872) | 3.18193326 |
| 102 | reverse cholesterol transport (GO:0043691) | 3.17587257 |
| 103 | urea metabolic process (GO:0019627) | 3.17547253 |
| 104 | urea cycle (GO:0000050) | 3.17547253 |
| 105 | regulation of cholesterol metabolic process (GO:0090181) | 3.17414337 |
| 106 | indolalkylamine metabolic process (GO:0006586) | 3.16838963 |
| 107 | neuron fate determination (GO:0048664) | 3.16029996 |
| 108 | xenobiotic catabolic process (GO:0042178) | 3.14683006 |
| 109 | regulation of fibrinolysis (GO:0051917) | 3.13061550 |
| 110 | proteasome assembly (GO:0043248) | 3.10846425 |
| 111 | regulation of fatty acid oxidation (GO:0046320) | 3.10215606 |
| 112 | small molecule catabolic process (GO:0044282) | 3.09774734 |
| 113 | flavonoid metabolic process (GO:0009812) | 3.09534468 |
| 114 | benzene-containing compound metabolic process (GO:0042537) | 3.09318221 |
| 115 | response to mercury ion (GO:0046689) | 3.07814206 |
| 116 | nitrogen cycle metabolic process (GO:0071941) | 3.03385564 |
| 117 | ubiquinone biosynthetic process (GO:0006744) | 3.02248942 |
| 118 | quinone biosynthetic process (GO:1901663) | 3.02248942 |
| 119 | regulation of complement activation (GO:0030449) | 3.00341279 |
| 120 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.99872569 |
| 121 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.99738589 |
| 122 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.98320527 |
| 123 | positive regulation of lipid catabolic process (GO:0050996) | 2.97789278 |
| 124 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.89039429 |
| 125 | protein-cofactor linkage (GO:0018065) | 2.88447838 |
| 126 | cullin deneddylation (GO:0010388) | 2.88154556 |
| 127 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.84165310 |
| 128 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.82378218 |
| 129 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.82378218 |
| 130 | inositol phosphate catabolic process (GO:0071545) | 2.82035689 |
| 131 | chaperone-mediated protein transport (GO:0072321) | 2.78279105 |
| 132 | nonmotile primary cilium assembly (GO:0035058) | 2.78158371 |
| 133 | negative regulation of heart rate (GO:0010459) | 2.76623966 |
| 134 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.76618637 |
| 135 | proton transport (GO:0015992) | 2.76335350 |
| 136 | intraciliary transport (GO:0042073) | 2.75248574 |
| 137 | hydrogen ion transmembrane transport (GO:1902600) | 2.74412946 |
| 138 | hydrogen transport (GO:0006818) | 2.72980533 |
| 139 | regulation of neurotransmitter uptake (GO:0051580) | 2.72826783 |
| 140 | L-methionine biosynthetic process (GO:0071265) | 2.71707675 |
| 141 | amino acid salvage (GO:0043102) | 2.71707675 |
| 142 | L-methionine salvage (GO:0071267) | 2.71707675 |
| 143 | adenosine metabolic process (GO:0046085) | 2.71282314 |
| 144 | aggressive behavior (GO:0002118) | 2.63940982 |
| 145 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.62503087 |
| 146 | regulation of sulfur metabolic process (GO:0042762) | 2.62256633 |
| 147 | protein localization to cilium (GO:0061512) | 2.60378505 |
| 148 | positive regulation of glycolytic process (GO:0045821) | 2.60300294 |
| 149 | anterograde synaptic vesicle transport (GO:0048490) | 2.60096034 |
| 150 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.59456131 |
| 151 | signal peptide processing (GO:0006465) | 2.59070194 |
| 152 | regulation of cilium movement (GO:0003352) | 2.58094679 |
| 153 | regulation of meiosis I (GO:0060631) | 2.57873012 |
| 154 | inositol phosphate dephosphorylation (GO:0046855) | 2.54850962 |
| 155 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.54850962 |
| 156 | C-terminal protein lipidation (GO:0006501) | 2.54094323 |
| 157 | protein deneddylation (GO:0000338) | 2.53470261 |
| 158 | GPI anchor metabolic process (GO:0006505) | 2.52209743 |
| 159 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.50075847 |
| 160 | positive regulation of meiosis (GO:0045836) | 2.49963991 |
| 161 | lactate metabolic process (GO:0006089) | 2.49961898 |
| 162 | regulation of oxidative phosphorylation (GO:0002082) | 2.49921763 |
| 163 | C4-dicarboxylate transport (GO:0015740) | 2.47580995 |
| 164 | ATP biosynthetic process (GO:0006754) | 2.45381726 |
| 165 | epithelial cilium movement (GO:0003351) | 2.44994657 |
| 166 | retinal cone cell development (GO:0046549) | 2.44843029 |
| 167 | intracellular protein transmembrane import (GO:0044743) | 2.44784137 |
| 168 | negative regulation of appetite (GO:0032099) | 2.43660170 |
| 169 | negative regulation of response to food (GO:0032096) | 2.43660170 |
| 170 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.39028847 |
| 171 | cilium morphogenesis (GO:0060271) | 2.38485670 |
| 172 | nitric oxide mediated signal transduction (GO:0007263) | 2.37885069 |
| 173 | oxidative phosphorylation (GO:0006119) | 2.36267956 |
| 174 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.34136335 |
| 175 | neurotransmitter catabolic process (GO:0042135) | 2.32969701 |
| 176 | peroxisome fission (GO:0016559) | 2.31140262 |
| 177 | prenylation (GO:0097354) | 2.31073223 |
| 178 | protein prenylation (GO:0018342) | 2.31073223 |
| 179 | GPI anchor biosynthetic process (GO:0006506) | 2.30700052 |
| 180 | mannosylation (GO:0097502) | 2.30698489 |
| 181 | C-terminal protein amino acid modification (GO:0018410) | 2.29640605 |
| 182 | polyol catabolic process (GO:0046174) | 2.29538500 |
| 183 | regulation of cofactor metabolic process (GO:0051193) | 2.28784227 |
| 184 | regulation of coenzyme metabolic process (GO:0051196) | 2.28784227 |
| 185 | rRNA modification (GO:0000154) | 2.27543179 |
| 186 | positive regulation of mitochondrial fission (GO:0090141) | 2.27226244 |
| 187 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.26743807 |
| 188 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.26743807 |
| 189 | nucleotide transmembrane transport (GO:1901679) | 2.26446773 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.32977317 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.68796023 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.75863358 |
| 4 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.96724424 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.79673090 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.49232314 |
| 7 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.96276234 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.92194420 |
| 9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.36574766 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.86575667 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.67198381 |
| 12 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.56111196 |
| 13 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.52502794 |
| 14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.32353569 |
| 15 | FUS_26573619_Chip-Seq_HEK293_Human | 2.21448974 |
| 16 | EWS_26573619_Chip-Seq_HEK293_Human | 2.19090476 |
| 17 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.17627370 |
| 18 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.08479031 |
| 19 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.02916787 |
| 20 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.01959021 |
| 21 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.98288253 |
| 22 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.94698400 |
| 23 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.92522456 |
| 24 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.90442352 |
| 25 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.78198612 |
| 26 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.75407198 |
| 27 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.72108123 |
| 28 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.71573188 |
| 29 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.68823111 |
| 30 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.68164721 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.67082977 |
| 32 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.64615493 |
| 33 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.52064725 |
| 34 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.49725212 |
| 35 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.48809099 |
| 36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.47042913 |
| 37 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.46447401 |
| 38 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.44992187 |
| 39 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.44577762 |
| 40 | AR_25329375_ChIP-Seq_VCAP_Human | 1.43536287 |
| 41 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.43024480 |
| 42 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.43013615 |
| 43 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.41507496 |
| 44 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.39573903 |
| 45 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.38621810 |
| 46 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.38404414 |
| 47 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.38404414 |
| 48 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.38264769 |
| 49 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.37946777 |
| 50 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.37716975 |
| 51 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.34821808 |
| 52 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.31428601 |
| 53 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.30602972 |
| 54 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.29901267 |
| 55 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.29304801 |
| 56 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.27479136 |
| 57 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.26410628 |
| 58 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24950798 |
| 59 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23684005 |
| 60 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.23682848 |
| 61 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.23428769 |
| 62 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.22954236 |
| 63 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.20787843 |
| 64 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.19564014 |
| 65 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.18779352 |
| 66 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.18487065 |
| 67 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.18466695 |
| 68 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18420194 |
| 69 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.17802419 |
| 70 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.17776770 |
| 71 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.16933441 |
| 72 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.14552585 |
| 73 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.14552585 |
| 74 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.14550821 |
| 75 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.14291453 |
| 76 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.14191015 |
| 77 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.13972932 |
| 78 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.13727177 |
| 79 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.13430043 |
| 80 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.12741711 |
| 81 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.12365155 |
| 82 | TCF4_23295773_ChIP-Seq_U87_Human | 1.11403283 |
| 83 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11264883 |
| 84 | STAT3_23295773_ChIP-Seq_U87_Human | 1.10864005 |
| 85 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.10499079 |
| 86 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.10427495 |
| 87 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.09665784 |
| 88 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.09377380 |
| 89 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.09181448 |
| 90 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.09008990 |
| 91 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.08000442 |
| 92 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.07725213 |
| 93 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.05258336 |
| 94 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.05048488 |
| 95 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.04840145 |
| 96 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.02969748 |
| 97 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01702917 |
| 98 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.01215048 |
| 99 | AR_20517297_ChIP-Seq_VCAP_Human | 1.01156577 |
| 100 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.99769219 |
| 101 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.99762316 |
| 102 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.95819834 |
| 103 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.95061435 |
| 104 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.93819566 |
| 105 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.92639513 |
| 106 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.92208128 |
| 107 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.89737391 |
| 108 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.88690880 |
| 109 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.87374673 |
| 110 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83718025 |
| 111 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.82994449 |
| 112 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.82416484 |
| 113 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.81887078 |
| 114 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.81611283 |
| 115 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.81036766 |
| 116 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.79601822 |
| 117 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.78584635 |
| 118 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.77962721 |
| 119 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.77513761 |
| 120 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77450713 |
| 121 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.75913671 |
| 122 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.75642993 |
| 123 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.75517496 |
| 124 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.75460272 |
| 125 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.74539865 |
| 126 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.74336645 |
| 127 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.74336645 |
| 128 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.73468642 |
| 129 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.72945345 |
| 130 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.70879813 |
| 131 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70865508 |
| 132 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.69393502 |
| 133 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.69310472 |
| 134 | VDR_22108803_ChIP-Seq_LS180_Human | 0.68454965 |
| 135 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.68105411 |
| 136 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.67811883 |
| 137 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.67063945 |
| 138 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.67004364 |
| 139 | CBP_21632823_ChIP-Seq_H3396_Human | 0.65943855 |
| 140 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.65104426 |
| 141 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.64565920 |
| 142 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.64505244 |
| 143 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.64198119 |
| 144 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.63669908 |
| 145 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.63233396 |
| 146 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.63189904 |
| 147 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.62536499 |
| 148 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.60459716 |
| 149 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.58938410 |
| 150 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.58284025 |
| 151 | P300_19829295_ChIP-Seq_ESCs_Human | 0.57608402 |
| 152 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.57571944 |
| 153 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.57097110 |
| 154 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.57018806 |
| 155 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.57007392 |
| 156 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.56858969 |
| 157 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.56858969 |
| 158 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.56214818 |
| 159 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.55321249 |
| 160 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.55148679 |
| 161 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.55148679 |
| 162 | CJUN_26792858_Chip-Seq_BT549_Human | 0.54587398 |
| 163 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.54081315 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.89382316 |
| 2 | MP0005360_urolithiasis | 5.60166047 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.96283625 |
| 4 | MP0005365_abnormal_bile_salt | 4.68867440 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.98013564 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.93558221 |
| 7 | MP0003195_calcinosis | 3.74635574 |
| 8 | MP0010329_abnormal_lipoprotein_level | 2.85004114 |
| 9 | MP0003252_abnormal_bile_duct | 2.83595016 |
| 10 | MP0005332_abnormal_amino_acid | 2.75094444 |
| 11 | MP0002837_dystrophic_cardiac_calcinosis | 2.58692335 |
| 12 | MP0009697_abnormal_copulation | 2.50259469 |
| 13 | MP0005670_abnormal_white_adipose | 2.42802877 |
| 14 | MP0008877_abnormal_DNA_methylation | 2.42439606 |
| 15 | MP0005646_abnormal_pituitary_gland | 2.34841530 |
| 16 | MP0006036_abnormal_mitochondrial_physio | 2.20299035 |
| 17 | MP0001529_abnormal_vocalization | 2.16249940 |
| 18 | MP0001666_abnormal_nutrient_absorption | 2.11443839 |
| 19 | MP0006072_abnormal_retinal_apoptosis | 2.08510895 |
| 20 | MP0004130_abnormal_muscle_cell | 2.05069812 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 2.04787309 |
| 22 | MP0003646_muscle_fatigue | 2.03611669 |
| 23 | MP0005645_abnormal_hypothalamus_physiol | 2.00909151 |
| 24 | MP0003787_abnormal_imprinting | 2.00281915 |
| 25 | MP0005083_abnormal_biliary_tract | 1.99273738 |
| 26 | MP0005084_abnormal_gallbladder_morpholo | 1.98011345 |
| 27 | MP0003186_abnormal_redox_activity | 1.95201111 |
| 28 | MP0003880_abnormal_central_pattern | 1.92961648 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 1.84915265 |
| 30 | MP0009046_muscle_twitch | 1.83535487 |
| 31 | MP0009840_abnormal_foam_cell | 1.82191576 |
| 32 | MP0002736_abnormal_nociception_after | 1.81620969 |
| 33 | MP0002638_abnormal_pupillary_reflex | 1.79310366 |
| 34 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.79144964 |
| 35 | MP0005253_abnormal_eye_physiology | 1.79015342 |
| 36 | MP0001968_abnormal_touch/_nociception | 1.78099867 |
| 37 | MP0002909_abnormal_adrenal_gland | 1.77832497 |
| 38 | MP0005551_abnormal_eye_electrophysiolog | 1.76931527 |
| 39 | MP0003136_yellow_coat_color | 1.75326837 |
| 40 | MP0004142_abnormal_muscle_tone | 1.72962326 |
| 41 | MP0002138_abnormal_hepatobiliary_system | 1.71242239 |
| 42 | MP0002971_abnormal_brown_adipose | 1.69246998 |
| 43 | MP0000372_irregular_coat_pigmentation | 1.66367008 |
| 44 | MP0001764_abnormal_homeostasis | 1.66358700 |
| 45 | MP0000609_abnormal_liver_physiology | 1.65628168 |
| 46 | MP0002102_abnormal_ear_morphology | 1.64580211 |
| 47 | MP0005319_abnormal_enzyme/_coenzyme | 1.62463104 |
| 48 | MP0002272_abnormal_nervous_system | 1.61730262 |
| 49 | MP0005535_abnormal_body_temperature | 1.61548232 |
| 50 | MP0001905_abnormal_dopamine_level | 1.60781687 |
| 51 | MP0004019_abnormal_vitamin_homeostasis | 1.58199440 |
| 52 | MP0003868_abnormal_feces_composition | 1.57679353 |
| 53 | MP0009745_abnormal_behavioral_response | 1.54336824 |
| 54 | MP0005666_abnormal_adipose_tissue | 1.51929287 |
| 55 | MP0006276_abnormal_autonomic_nervous | 1.47563921 |
| 56 | MP0005379_endocrine/exocrine_gland_phen | 1.46200692 |
| 57 | MP0005330_cardiomyopathy | 1.46038607 |
| 58 | MP0002332_abnormal_exercise_endurance | 1.45923699 |
| 59 | MP0000631_abnormal_neuroendocrine_gland | 1.42508684 |
| 60 | MP0004270_analgesia | 1.41799186 |
| 61 | MP0000749_muscle_degeneration | 1.40764076 |
| 62 | MP0009643_abnormal_urine_homeostasis | 1.40678308 |
| 63 | MP0008872_abnormal_physiological_respon | 1.40443154 |
| 64 | MP0004145_abnormal_muscle_electrophysio | 1.40162881 |
| 65 | MP0001188_hyperpigmentation | 1.39663370 |
| 66 | MP0004885_abnormal_endolymph | 1.39137519 |
| 67 | MP0005167_abnormal_blood-brain_barrier | 1.39010372 |
| 68 | MP0000516_abnormal_urinary_system | 1.38387082 |
| 69 | MP0005367_renal/urinary_system_phenotyp | 1.38387082 |
| 70 | MP0001486_abnormal_startle_reflex | 1.38163388 |
| 71 | MP0008789_abnormal_olfactory_epithelium | 1.35844814 |
| 72 | MP0003122_maternal_imprinting | 1.32504041 |
| 73 | MP0003724_increased_susceptibility_to | 1.30184609 |
| 74 | MP0004043_abnormal_pH_regulation | 1.29672097 |
| 75 | MP0001485_abnormal_pinna_reflex | 1.29635293 |
| 76 | MP0003011_delayed_dark_adaptation | 1.29508414 |
| 77 | MP0008995_early_reproductive_senescence | 1.28790657 |
| 78 | MP0003121_genomic_imprinting | 1.26786133 |
| 79 | MP0002234_abnormal_pharynx_morphology | 1.24843511 |
| 80 | MP0006292_abnormal_olfactory_placode | 1.21326800 |
| 81 | MP0004147_increased_porphyrin_level | 1.20463148 |
| 82 | MP0002090_abnormal_vision | 1.19189185 |
| 83 | MP0008058_abnormal_DNA_repair | 1.18786564 |
| 84 | MP0002078_abnormal_glucose_homeostasis | 1.17784999 |
| 85 | MP0002938_white_spotting | 1.17761495 |
| 86 | MP0002876_abnormal_thyroid_physiology | 1.15148705 |
| 87 | MP0005451_abnormal_body_composition | 1.13387933 |
| 88 | MP0002064_seizures | 1.12494138 |
| 89 | MP0005248_abnormal_Harderian_gland | 1.12372476 |
| 90 | MP0002572_abnormal_emotion/affect_behav | 1.10384689 |
| 91 | MP0010368_abnormal_lymphatic_system | 1.09189810 |
| 92 | MP0004036_abnormal_muscle_relaxation | 1.08726101 |
| 93 | MP0006035_abnormal_mitochondrial_morpho | 1.06745590 |
| 94 | MP0005187_abnormal_penis_morphology | 1.06492388 |
| 95 | MP0003786_premature_aging | 1.06185590 |
| 96 | MP0005636_abnormal_mineral_homeostasis | 1.05948126 |
| 97 | MP0001970_abnormal_pain_threshold | 1.05440656 |
| 98 | MP0005266_abnormal_metabolism | 1.04506323 |
| 99 | MP0009764_decreased_sensitivity_to | 1.04051535 |
| 100 | MP0003656_abnormal_erythrocyte_physiolo | 1.03784804 |
| 101 | MP0003221_abnormal_cardiomyocyte_apopto | 1.03688993 |
| 102 | MP0010386_abnormal_urinary_bladder | 1.03167482 |
| 103 | MP0002734_abnormal_mechanical_nocicepti | 1.02585724 |
| 104 | MP0005334_abnormal_fat_pad | 1.02349280 |
| 105 | MP0003690_abnormal_glial_cell | 1.01324015 |
| 106 | MP0003633_abnormal_nervous_system | 1.00834611 |
| 107 | MP0003950_abnormal_plasma_membrane | 0.99742964 |
| 108 | MP0001944_abnormal_pancreas_morphology | 0.99643230 |
| 109 | MP0002067_abnormal_sensory_capabilities | 0.97990228 |
| 110 | MP0000230_abnormal_systemic_arterial | 0.96850608 |
| 111 | MP0009780_abnormal_chondrocyte_physiolo | 0.96615653 |
| 112 | MP0003718_maternal_effect | 0.94450378 |
| 113 | MP0003635_abnormal_synaptic_transmissio | 0.94269072 |
| 114 | MP0004924_abnormal_behavior | 0.94134677 |
| 115 | MP0005386_behavior/neurological_phenoty | 0.94134677 |
| 116 | MP0005376_homeostasis/metabolism_phenot | 0.93420185 |
| 117 | MP0004085_abnormal_heartbeat | 0.93160331 |
| 118 | MP0002733_abnormal_thermal_nociception | 0.90831249 |
| 119 | MP0002557_abnormal_social/conspecific_i | 0.89696714 |
| 120 | MP0004133_heterotaxia | 0.87924630 |
| 121 | MP0005448_abnormal_energy_balance | 0.86766460 |
| 122 | MP0005220_abnormal_exocrine_pancreas | 0.85563062 |
| 123 | MP0002693_abnormal_pancreas_physiology | 0.84807318 |
| 124 | MP0000639_abnormal_adrenal_gland | 0.84240253 |
| 125 | MP0002972_abnormal_cardiac_muscle | 0.84102858 |
| 126 | MP0005171_absent_coat_pigmentation | 0.83760253 |
| 127 | MP0001853_heart_inflammation | 0.82187930 |
| 128 | MP0005620_abnormal_muscle_contractility | 0.81716621 |
| 129 | MP0005647_abnormal_sex_gland | 0.81523347 |
| 130 | MP0009763_increased_sensitivity_to | 0.81313489 |
| 131 | MP0009642_abnormal_blood_homeostasis | 0.81222211 |
| 132 | MP0008469_abnormal_protein_level | 0.80754565 |
| 133 | MP0004185_abnormal_adipocyte_glucose | 0.80678905 |
| 134 | MP0002822_catalepsy | 0.80544355 |
| 135 | MP0005375_adipose_tissue_phenotype | 0.80019134 |
| 136 | MP0001879_abnormal_lymphatic_vessel | 0.79450279 |
| 137 | MP0000598_abnormal_liver_morphology | 0.78620036 |
| 138 | MP0005408_hypopigmentation | 0.78362247 |
| 139 | MP0000013_abnormal_adipose_tissue | 0.76522873 |
| 140 | MP0004215_abnormal_myocardial_fiber | 0.76501057 |
| 141 | MP0008775_abnormal_heart_ventricle | 0.74846570 |
| 142 | MP0001756_abnormal_urination | 0.70206973 |
| 143 | MP0004381_abnormal_hair_follicle | 0.69231271 |
| 144 | MP0005595_abnormal_vascular_smooth | 0.67145808 |
| 145 | MP0002970_abnormal_white_adipose | 0.66799322 |
| 146 | MP0005385_cardiovascular_system_phenoty | 0.65270709 |
| 147 | MP0001544_abnormal_cardiovascular_syste | 0.65270709 |
| 148 | MP0004084_abnormal_cardiac_muscle | 0.64927649 |
| 149 | MP0009765_abnormal_xenobiotic_induced | 0.63480505 |
| 150 | MP0001661_extended_life_span | 0.62012653 |
| 151 | MP0001984_abnormal_olfaction | 0.59006646 |
| 152 | MP0000343_altered_response_to | 0.56783415 |
| 153 | MP0003953_abnormal_hormone_level | 0.56500588 |
| 154 | MP0006138_congestive_heart_failure | 0.56430912 |
| 155 | MP0002877_abnormal_melanocyte_morpholog | 0.55787600 |
| 156 | MP0000747_muscle_weakness | 0.54756094 |
| 157 | MP0009379_abnormal_foot_pigmentation | 0.53828930 |
| 158 | MP0005165_increased_susceptibility_to | 0.53323416 |
| 159 | MP0004484_altered_response_of | 0.52435641 |
| 160 | MP0003137_abnormal_impulse_conducting | 0.51163501 |
| 161 | MP0004087_abnormal_muscle_fiber | 0.50169135 |
| 162 | MP0005058_abnormal_lysosome_morphology | 0.49750783 |
| 163 | MP0003959_abnormal_lean_body | 0.47662955 |
| 164 | MP0000751_myopathy | 0.45978644 |
| 165 | MP0000920_abnormal_myelination | 0.45504611 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.13808466 |
| 2 | Hypoglycemic coma (HP:0001325) | 4.80470543 |
| 3 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.31687505 |
| 4 | Cerebral edema (HP:0002181) | 4.31047932 |
| 5 | Acute encephalopathy (HP:0006846) | 4.29885996 |
| 6 | Hepatic necrosis (HP:0002605) | 4.26113539 |
| 7 | Acute necrotizing encephalopathy (HP:0006965) | 4.24616609 |
| 8 | Intrahepatic cholestasis (HP:0001406) | 4.23556711 |
| 9 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.16941872 |
| 10 | Hyperglycinuria (HP:0003108) | 3.98611372 |
| 11 | Ketosis (HP:0001946) | 3.97379041 |
| 12 | Xanthomatosis (HP:0000991) | 3.89724791 |
| 13 | Prolonged partial thromboplastin time (HP:0003645) | 3.87625250 |
| 14 | Dicarboxylic aciduria (HP:0003215) | 3.85728411 |
| 15 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.85728411 |
| 16 | Abnormality of glycine metabolism (HP:0010895) | 3.85463970 |
| 17 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.85463970 |
| 18 | Hyperammonemia (HP:0001987) | 3.81970372 |
| 19 | Generalized aminoaciduria (HP:0002909) | 3.80573443 |
| 20 | Hyperglycinemia (HP:0002154) | 3.72170355 |
| 21 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.60346076 |
| 22 | Ketoacidosis (HP:0001993) | 3.56731998 |
| 23 | Hypobetalipoproteinemia (HP:0003563) | 3.54540364 |
| 24 | Myoglobinuria (HP:0002913) | 3.53934039 |
| 25 | Hepatocellular necrosis (HP:0001404) | 3.52940113 |
| 26 | Progressive macrocephaly (HP:0004481) | 3.52812282 |
| 27 | Deep venous thrombosis (HP:0002625) | 3.46526182 |
| 28 | Hyperlipoproteinemia (HP:0010980) | 3.45729120 |
| 29 | Increased hepatocellular lipid droplets (HP:0006565) | 3.42040530 |
| 30 | Lethargy (HP:0001254) | 3.38572625 |
| 31 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.33327494 |
| 32 | Mitochondrial inheritance (HP:0001427) | 3.28716087 |
| 33 | Abnormality of serum amino acid levels (HP:0003112) | 3.19675378 |
| 34 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.16361966 |
| 35 | Increased CSF lactate (HP:0002490) | 3.10353346 |
| 36 | Renal Fanconi syndrome (HP:0001994) | 3.07846823 |
| 37 | Lactic acidosis (HP:0003128) | 3.02622761 |
| 38 | Joint hemorrhage (HP:0005261) | 3.01293454 |
| 39 | Hypolipoproteinemia (HP:0010981) | 3.00357353 |
| 40 | Metabolic acidosis (HP:0001942) | 3.00061321 |
| 41 | Medial flaring of the eyebrow (HP:0010747) | 2.99405669 |
| 42 | Increased serum pyruvate (HP:0003542) | 2.95564201 |
| 43 | Abnormality of glycolysis (HP:0004366) | 2.95564201 |
| 44 | Hypoalphalipoproteinemia (HP:0003233) | 2.88776890 |
| 45 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.87180643 |
| 46 | Renal cortical cysts (HP:0000803) | 2.84178964 |
| 47 | Proximal tubulopathy (HP:0000114) | 2.82475245 |
| 48 | Increased muscle lipid content (HP:0009058) | 2.81822452 |
| 49 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.80504665 |
| 50 | Abnormality of the intrinsic pathway (HP:0010989) | 2.79554007 |
| 51 | Complement deficiency (HP:0004431) | 2.78638884 |
| 52 | Abnormality of methionine metabolism (HP:0010901) | 2.75670956 |
| 53 | Pancreatic fibrosis (HP:0100732) | 2.75043551 |
| 54 | Vomiting (HP:0002013) | 2.69556447 |
| 55 | Delayed CNS myelination (HP:0002188) | 2.68656584 |
| 56 | Hypothermia (HP:0002045) | 2.67074225 |
| 57 | Epidermoid cyst (HP:0200040) | 2.66138822 |
| 58 | Abnormality of the common coagulation pathway (HP:0010990) | 2.64919794 |
| 59 | Ragged-red muscle fibers (HP:0003200) | 2.64053306 |
| 60 | Pancreatic cysts (HP:0001737) | 2.63912241 |
| 61 | Hypercholesterolemia (HP:0003124) | 2.57373577 |
| 62 | Abnormality of urine glucose concentration (HP:0011016) | 2.57287545 |
| 63 | Glycosuria (HP:0003076) | 2.57287545 |
| 64 | Fat malabsorption (HP:0002630) | 2.56584929 |
| 65 | Conjugated hyperbilirubinemia (HP:0002908) | 2.56020193 |
| 66 | Methylmalonic aciduria (HP:0012120) | 2.55031918 |
| 67 | Congenital, generalized hypertrichosis (HP:0004540) | 2.54109032 |
| 68 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.53692143 |
| 69 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.53692143 |
| 70 | True hermaphroditism (HP:0010459) | 2.53322544 |
| 71 | Abnormality of vitamin B metabolism (HP:0004340) | 2.50897728 |
| 72 | Exertional dyspnea (HP:0002875) | 2.50711859 |
| 73 | Rhabdomyolysis (HP:0003201) | 2.47218859 |
| 74 | Respiratory failure (HP:0002878) | 2.43879571 |
| 75 | Molar tooth sign on MRI (HP:0002419) | 2.41044486 |
| 76 | Abnormality of midbrain morphology (HP:0002418) | 2.41044486 |
| 77 | Lipid accumulation in hepatocytes (HP:0006561) | 2.40663309 |
| 78 | Hypoglycemic seizures (HP:0002173) | 2.39684830 |
| 79 | Nausea (HP:0002018) | 2.39409422 |
| 80 | Abnormality of the renal cortex (HP:0011035) | 2.39174388 |
| 81 | Gait imbalance (HP:0002141) | 2.39086716 |
| 82 | Congenital primary aphakia (HP:0007707) | 2.37965941 |
| 83 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.37828488 |
| 84 | Increased intramyocellular lipid droplets (HP:0012240) | 2.36714445 |
| 85 | Nephronophthisis (HP:0000090) | 2.35692372 |
| 86 | Methylmalonic acidemia (HP:0002912) | 2.34164579 |
| 87 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.33841863 |
| 88 | Large for gestational age (HP:0001520) | 2.32431183 |
| 89 | Hyperphosphaturia (HP:0003109) | 2.32087188 |
| 90 | Abolished electroretinogram (ERG) (HP:0000550) | 2.30831074 |
| 91 | Hyperbilirubinemia (HP:0002904) | 2.29825437 |
| 92 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.27216431 |
| 93 | Abnormality of alanine metabolism (HP:0010916) | 2.27216431 |
| 94 | Hyperalaninemia (HP:0003348) | 2.27216431 |
| 95 | Nephrogenic diabetes insipidus (HP:0009806) | 2.26607677 |
| 96 | Exercise intolerance (HP:0003546) | 2.26411778 |
| 97 | Exercise-induced muscle cramps (HP:0003710) | 2.25436917 |
| 98 | Leukodystrophy (HP:0002415) | 2.25340075 |
| 99 | Pancreatitis (HP:0001733) | 2.22559364 |
| 100 | Respiratory distress (HP:0002098) | 2.21767022 |
| 101 | Calf muscle hypertrophy (HP:0008981) | 2.19438036 |
| 102 | Optic disc pallor (HP:0000543) | 2.18992118 |
| 103 | Palpitations (HP:0001962) | 2.18697819 |
| 104 | Increased serum lactate (HP:0002151) | 2.15869270 |
| 105 | Neuroendocrine neoplasm (HP:0100634) | 2.15211711 |
| 106 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.14370420 |
| 107 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.08482389 |
| 108 | Abnormality of renal resorption (HP:0011038) | 2.05654684 |
| 109 | Abnormality of the renal medulla (HP:0100957) | 2.05338954 |
| 110 | Steatorrhea (HP:0002570) | 2.04377290 |
| 111 | Hemiparesis (HP:0001269) | 2.04249123 |
| 112 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.03154147 |
| 113 | 3-Methylglutaconic aciduria (HP:0003535) | 2.02732022 |
| 114 | Abnormality of purine metabolism (HP:0004352) | 2.00324706 |
| 115 | Hypomagnesemia (HP:0002917) | 1.97058009 |
| 116 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.95776529 |
| 117 | Intestinal atresia (HP:0011100) | 1.95745399 |
| 118 | Cerebral palsy (HP:0100021) | 1.95264602 |
| 119 | Hyperglycemia (HP:0003074) | 1.95020255 |
| 120 | Symptomatic seizures (HP:0011145) | 1.94648831 |
| 121 | Genital tract atresia (HP:0001827) | 1.93098342 |
| 122 | Congenital stationary night blindness (HP:0007642) | 1.92539287 |
| 123 | Abnormality of complement system (HP:0005339) | 1.91419523 |
| 124 | Oligomenorrhea (HP:0000876) | 1.91049574 |
| 125 | Hydroxyprolinuria (HP:0003080) | 1.90857378 |
| 126 | Abnormality of proline metabolism (HP:0010907) | 1.90857378 |
| 127 | Abnormal gallbladder morphology (HP:0012437) | 1.90193489 |
| 128 | Spastic paraparesis (HP:0002313) | 1.88644253 |
| 129 | Elevated hepatic transaminases (HP:0002910) | 1.87633363 |
| 130 | Abnormality of nucleobase metabolism (HP:0010932) | 1.86374064 |
| 131 | CNS demyelination (HP:0007305) | 1.85514721 |
| 132 | Brushfield spots (HP:0001088) | 1.85134243 |
| 133 | Median cleft lip (HP:0000161) | 1.79571620 |
| 134 | Febrile seizures (HP:0002373) | 1.76404696 |
| 135 | Polydipsia (HP:0001959) | 1.76146546 |
| 136 | Abnormal drinking behavior (HP:0030082) | 1.76146546 |
| 137 | Abnormality of vitamin metabolism (HP:0100508) | 1.75402218 |
| 138 | Neoplasm of the adrenal gland (HP:0100631) | 1.75178873 |
| 139 | Vaginal atresia (HP:0000148) | 1.74884462 |
| 140 | Male pseudohermaphroditism (HP:0000037) | 1.73092284 |
| 141 | Abnormality of the fovea (HP:0000493) | 1.72225084 |
| 142 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.70390703 |
| 143 | Hypoplasia of the fovea (HP:0007750) | 1.70390703 |
| 144 | Pheochromocytoma (HP:0002666) | 1.69955745 |
| 145 | Left ventricular hypertrophy (HP:0001712) | 1.69687696 |
| 146 | Limb dystonia (HP:0002451) | 1.69249099 |
| 147 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.68390881 |
| 148 | Focal motor seizures (HP:0011153) | 1.65999530 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.43024414 |
| 2 | MAP4K2 | 2.71646465 |
| 3 | PINK1 | 2.60206110 |
| 4 | MUSK | 2.57964774 |
| 5 | NME2 | 2.39084927 |
| 6 | NEK9 | 2.38601402 |
| 7 | MYLK | 2.35253382 |
| 8 | MST1R | 2.28270730 |
| 9 | IRAK3 | 2.24779652 |
| 10 | INSRR | 2.17784627 |
| 11 | PDK3 | 2.10138054 |
| 12 | PDK4 | 2.10138054 |
| 13 | OBSCN | 2.04604196 |
| 14 | TIE1 | 1.95584830 |
| 15 | PLK2 | 1.85328107 |
| 16 | STK38L | 1.84042185 |
| 17 | STK16 | 1.77725911 |
| 18 | MAP3K4 | 1.76913231 |
| 19 | PIK3CG | 1.75940741 |
| 20 | PBK | 1.71854542 |
| 21 | PNCK | 1.60965806 |
| 22 | SIK1 | 1.55929653 |
| 23 | MAPK15 | 1.55025180 |
| 24 | CSNK1G2 | 1.50515704 |
| 25 | EIF2AK1 | 1.49494820 |
| 26 | PDK2 | 1.49246851 |
| 27 | PIK3CA | 1.47742796 |
| 28 | FGFR4 | 1.47552569 |
| 29 | IRAK1 | 1.45494406 |
| 30 | FLT3 | 1.43620887 |
| 31 | GRK7 | 1.42664811 |
| 32 | STK39 | 1.40732210 |
| 33 | TRIM28 | 1.40368101 |
| 34 | VRK1 | 1.40074897 |
| 35 | CSNK1G3 | 1.39142864 |
| 36 | WNK4 | 1.38488423 |
| 37 | EIF2AK3 | 1.27618410 |
| 38 | MAPK13 | 1.24704462 |
| 39 | MAP3K14 | 1.21959839 |
| 40 | PHKG2 | 1.21794922 |
| 41 | PHKG1 | 1.21794922 |
| 42 | VRK2 | 1.21466969 |
| 43 | TGFBR2 | 1.20478380 |
| 44 | FER | 1.16501862 |
| 45 | MST4 | 1.14264038 |
| 46 | MAP3K12 | 1.10030986 |
| 47 | PAK3 | 1.08536806 |
| 48 | PLK3 | 1.07842614 |
| 49 | IRAK4 | 1.05485451 |
| 50 | BMPR1B | 1.04994843 |
| 51 | ERN1 | 1.02445403 |
| 52 | OXSR1 | 1.00455613 |
| 53 | CCNB1 | 0.95414303 |
| 54 | GRK1 | 0.95336739 |
| 55 | NTRK3 | 0.93484259 |
| 56 | MAP2K7 | 0.92671741 |
| 57 | ERBB4 | 0.91539333 |
| 58 | CASK | 0.91122668 |
| 59 | STK24 | 0.90265800 |
| 60 | CSNK1A1L | 0.89570452 |
| 61 | MARK1 | 0.89257417 |
| 62 | MAP2K4 | 0.89002850 |
| 63 | IRAK2 | 0.88506420 |
| 64 | TNIK | 0.87250324 |
| 65 | DYRK2 | 0.86881153 |
| 66 | PRKAA2 | 0.85059084 |
| 67 | MKNK2 | 0.84748734 |
| 68 | ABL2 | 0.82437691 |
| 69 | TEC | 0.81806275 |
| 70 | EPHA4 | 0.80931011 |
| 71 | BMPR2 | 0.80065549 |
| 72 | PKN1 | 0.79756068 |
| 73 | DAPK2 | 0.79528538 |
| 74 | PRKCG | 0.79178701 |
| 75 | CAMK2G | 0.77382625 |
| 76 | SGK223 | 0.76828014 |
| 77 | SGK494 | 0.76828014 |
| 78 | AKT3 | 0.75232466 |
| 79 | FRK | 0.74617700 |
| 80 | MET | 0.73801916 |
| 81 | CAMK2D | 0.73443014 |
| 82 | NUAK1 | 0.73081484 |
| 83 | MKNK1 | 0.72516609 |
| 84 | EPHB1 | 0.70562486 |
| 85 | NEK1 | 0.68613016 |
| 86 | EPHA3 | 0.64959758 |
| 87 | GRK5 | 0.63602455 |
| 88 | STK3 | 0.63054435 |
| 89 | LIMK1 | 0.63023714 |
| 90 | ERBB3 | 0.62188579 |
| 91 | TLK1 | 0.60663140 |
| 92 | PRKCE | 0.60509652 |
| 93 | MINK1 | 0.60096582 |
| 94 | CAMKK2 | 0.59532202 |
| 95 | MAPK4 | 0.56921985 |
| 96 | PRKACG | 0.56062279 |
| 97 | PRKG1 | 0.55302889 |
| 98 | PTK2B | 0.55068641 |
| 99 | SGK2 | 0.54247437 |
| 100 | CSNK1G1 | 0.54032496 |
| 101 | WEE1 | 0.53963015 |
| 102 | MAP3K3 | 0.53773617 |
| 103 | MAPKAPK3 | 0.53705658 |
| 104 | FGFR2 | 0.52410159 |
| 105 | ADRBK1 | 0.52056913 |
| 106 | RPS6KA5 | 0.50110439 |
| 107 | ADRBK2 | 0.49691819 |
| 108 | BCR | 0.48881783 |
| 109 | YES1 | 0.48407979 |
| 110 | MAP3K5 | 0.48381833 |
| 111 | GSK3A | 0.48170686 |
| 112 | NLK | 0.47736727 |
| 113 | TAOK3 | 0.47053318 |
| 114 | WNK3 | 0.46674405 |
| 115 | DYRK3 | 0.46106471 |
| 116 | PRKCQ | 0.45427965 |
| 117 | CSNK1A1 | 0.45207242 |
| 118 | JAK2 | 0.44020868 |
| 119 | NME1 | 0.43500938 |
| 120 | PRKACA | 0.43405483 |
| 121 | MAPKAPK5 | 0.42821325 |
| 122 | CAMK2B | 0.42332847 |
| 123 | CAMK2A | 0.42328015 |
| 124 | ROCK1 | 0.41540046 |
| 125 | CDK3 | 0.41400831 |
| 126 | CSK | 0.40862481 |
| 127 | LMTK2 | 0.40714662 |
| 128 | PIM2 | 0.39431787 |
| 129 | MAPK11 | 0.37831535 |
| 130 | JAK1 | 0.37686139 |
| 131 | NTRK2 | 0.37661950 |
| 132 | PRKAA1 | 0.37153199 |
| 133 | TNK2 | 0.36858299 |
| 134 | CAMK1 | 0.36729326 |
| 135 | TXK | 0.36472099 |
| 136 | MAPK7 | 0.36309734 |
| 137 | BRSK2 | 0.36294607 |
| 138 | IGF1R | 0.35644670 |
| 139 | TYK2 | 0.35368956 |
| 140 | ACVR1B | 0.34992081 |
| 141 | TBK1 | 0.34069950 |
| 142 | PRKACB | 0.33517893 |
| 143 | ZAK | 0.32888113 |
| 144 | PDPK1 | 0.32796845 |
| 145 | PLK4 | 0.31964562 |
| 146 | IKBKE | 0.31075298 |
| 147 | MAP2K6 | 0.30477833 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.25138932 |
| 2 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.24048096 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.10757735 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.05466717 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.71952889 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62680295 |
| 7 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.55278123 |
| 8 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.50773404 |
| 9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.50180505 |
| 10 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.45901685 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.30699805 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.26665008 |
| 13 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.25690973 |
| 14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.24793414 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.24423371 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.08206878 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.07401481 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.05242106 |
| 19 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.04888108 |
| 20 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.01129606 |
| 21 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.98691792 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.97270616 |
| 23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.88422301 |
| 24 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.88303435 |
| 25 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.80450035 |
| 26 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.79223057 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73039811 |
| 28 | Parkinsons disease_Homo sapiens_hsa05012 | 1.71999069 |
| 29 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.68554040 |
| 30 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.62137239 |
| 31 | Carbon metabolism_Homo sapiens_hsa01200 | 1.60006142 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.54989718 |
| 33 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.54857258 |
| 34 | Histidine metabolism_Homo sapiens_hsa00340 | 1.54479135 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.49829788 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.47017821 |
| 37 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.45565572 |
| 38 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.45447568 |
| 39 | Retinol metabolism_Homo sapiens_hsa00830 | 1.37974878 |
| 40 | Phototransduction_Homo sapiens_hsa04744 | 1.32931750 |
| 41 | Protein export_Homo sapiens_hsa03060 | 1.31524492 |
| 42 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.31425825 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.30593029 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28390672 |
| 45 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.27902466 |
| 46 | Basal transcription factors_Homo sapiens_hsa03022 | 1.24510747 |
| 47 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.23561386 |
| 48 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.20996554 |
| 49 | Alzheimers disease_Homo sapiens_hsa05010 | 1.17476217 |
| 50 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.16743552 |
| 51 | Homologous recombination_Homo sapiens_hsa03440 | 1.15755911 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.13881365 |
| 53 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.09478676 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.09178996 |
| 55 | GABAergic synapse_Homo sapiens_hsa04727 | 1.06676216 |
| 56 | RNA polymerase_Homo sapiens_hsa03020 | 1.06018640 |
| 57 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.05568794 |
| 58 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.04378841 |
| 59 | RNA degradation_Homo sapiens_hsa03018 | 1.03423630 |
| 60 | Nicotine addiction_Homo sapiens_hsa05033 | 0.97258336 |
| 61 | Huntingtons disease_Homo sapiens_hsa05016 | 0.93889576 |
| 62 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.92040583 |
| 63 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.91813162 |
| 64 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.89905629 |
| 65 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.89887243 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85684277 |
| 67 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.83316256 |
| 68 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.83176960 |
| 69 | ABC transporters_Homo sapiens_hsa02010 | 0.82830711 |
| 70 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.80066114 |
| 71 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.79813211 |
| 72 | Metabolic pathways_Homo sapiens_hsa01100 | 0.79117693 |
| 73 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.77597804 |
| 74 | Bile secretion_Homo sapiens_hsa04976 | 0.77386160 |
| 75 | Insulin secretion_Homo sapiens_hsa04911 | 0.76624523 |
| 76 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.76124041 |
| 77 | Circadian entrainment_Homo sapiens_hsa04713 | 0.76067132 |
| 78 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.76037153 |
| 79 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72696294 |
| 80 | Ribosome_Homo sapiens_hsa03010 | 0.69114794 |
| 81 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68980259 |
| 82 | Olfactory transduction_Homo sapiens_hsa04740 | 0.68795386 |
| 83 | Sulfur relay system_Homo sapiens_hsa04122 | 0.68560652 |
| 84 | Morphine addiction_Homo sapiens_hsa05032 | 0.68072938 |
| 85 | Purine metabolism_Homo sapiens_hsa00230 | 0.67863969 |
| 86 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.63705776 |
| 87 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.63188524 |
| 88 | Mismatch repair_Homo sapiens_hsa03430 | 0.62257266 |
| 89 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.61855063 |
| 90 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.61624706 |
| 91 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.61304752 |
| 92 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.60985915 |
| 93 | Renin secretion_Homo sapiens_hsa04924 | 0.59640178 |
| 94 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.56259895 |
| 95 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.55232953 |
| 96 | Asthma_Homo sapiens_hsa05310 | 0.51904885 |
| 97 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.49275088 |
| 98 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.48883624 |
| 99 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.48556597 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.48265081 |
| 101 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.47568018 |
| 102 | Taste transduction_Homo sapiens_hsa04742 | 0.47481188 |
| 103 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.45755614 |
| 104 | Cocaine addiction_Homo sapiens_hsa05030 | 0.45633162 |
| 105 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.45162303 |
| 106 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42188809 |
| 107 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.40868088 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38427129 |
| 109 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.38378495 |
| 110 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.37675412 |
| 111 | Long-term depression_Homo sapiens_hsa04730 | 0.37272671 |
| 112 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36446158 |
| 113 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.35904698 |
| 114 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.34216647 |
| 115 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31321969 |
| 116 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.30349269 |
| 117 | Lysine degradation_Homo sapiens_hsa00310 | 0.25388439 |
| 118 | Insulin resistance_Homo sapiens_hsa04931 | 0.25369294 |
| 119 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.24990951 |
| 120 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.24691976 |
| 121 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.21330604 |
| 122 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.20265742 |
| 123 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.17579049 |
| 124 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14964164 |
| 125 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.09280995 |
| 126 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.08228585 |
| 127 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.06280421 |
| 128 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.06156655 |
| 129 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.04844307 |
| 130 | Other glycan degradation_Homo sapiens_hsa00511 | 0.04283473 |
| 131 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03295220 |
| 132 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.01670723 |
| 133 | Prion diseases_Homo sapiens_hsa05020 | 0.01427690 |
| 134 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0925417 |
| 135 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0661913 |
| 136 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.0407120 |
| 137 | Proteasome_Homo sapiens_hsa03050 | -0.0311178 |

